Table 2. Analysis of glucocorticoid use and condition on admission in SMPP.
| Condition on admission | Glucocorticoid use (N=31) | Normal treatment (N=28) | t/χ2 | P value |
|---|---|---|---|---|
| Fever before admission (days) | 7.09±5.70 | 4.39±3.34 | 2.191 | 0.033 |
| Cough before admission (days) | 9.96±7.56 | 7.17±5.54 | 1.16 | 0.251 |
| Maximum temperature before admission | 39.32±0.88 | 39.40±1.29 | −0.26 | 0.796 |
| WBC after admission (109/L) | 10.34±5.42 | 9.67±3.76 | 0.539 | 0.592 |
| CRP after admission (mg/L) | 21.20±19.39 | 16.63±11.17 | 0.795 | 0.43 |
| PLT after admission (109/L) | 355.03±144.39 | 309.85±173.01 | 1.093 | 0.279 |
| MP titer after admission (1:X) | 370.32±258.19 | 253.24±159.14 | 1.784 | 0.081 |
SMPP, severe Mycoplasma pneumoniae pneumonia; MP, Mycoplasma pneumoniae; WBC, white blood cell; CRP, C-reactive protein; PLT, platelet.